日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Macaca fascicularis Ankyrin repeat and SOCS box protein 17 (ASB17) CSB-YP842562MOV
CSB-EP842562MOV
CSB-BP842562MOV
CSB-MP842562MOV
CSB-EP842562MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis SUN domain-containing protein 3 (SUN3) CSB-YP842563MOV
CSB-EP842563MOV
CSB-BP842563MOV
CSB-MP842563MOV
CSB-EP842563MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Mu-type opioid receptor (OPRM1), partial CSB-YP842565MOV1
CSB-EP842565MOV1
CSB-BP842565MOV1
CSB-MP842565MOV1
CSB-EP842565MOV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pig Ammonium transporter Rh type B (RHBG), partial CSB-YP842566PI
CSB-EP842566PI
CSB-BP842566PI
CSB-MP842566PI
CSB-EP842566PI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pan troglodytes NKG2-F type II integral membrane protein (KLRC4), partial CSB-YP842567EQV
CSB-EP842567EQV
CSB-BP842567EQV
CSB-MP842567EQV
CSB-EP842567EQV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rabbit Proteolipid protein 2 (PLP2), partial CSB-YP842568RB1
CSB-EP842568RB1
CSB-BP842568RB1
CSB-MP842568RB1
CSB-EP842568RB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dog Ferritin heavy chain (FTH1) CSB-YP842569DO
CSB-EP842569DO
CSB-BP842569DO
CSB-MP842569DO
CSB-EP842569DO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hylobates moloch C-C chemokine receptor type 5 (CCR5), partial CSB-YP842570HRG1
CSB-EP842570HRG1
CSB-BP842570HRG1
CSB-MP842570HRG1
CSB-EP842570HRG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Colobus polykomos C-C chemokine receptor type 5 (CCR5), partial CSB-YP842571DVI1
CSB-EP842571DVI1
CSB-BP842571DVI1
CSB-MP842571DVI1
CSB-EP842571DVI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Scutigera coleoptrata Hemocyanin subunit D (HCD), partial CSB-YP842572SIAV
CSB-EP842572SIAV
CSB-BP842572SIAV
CSB-MP842572SIAV
CSB-EP842572SIAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Hybrid signal transduction histidine kinase C (dhkC), partial CSB-YP842573DKK
CSB-EP842573DKK
CSB-BP842573DKK
CSB-MP842573DKK
CSB-EP842573DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mediator of RNA polymerase II transcription subunit 7 (let-49) CSB-YP842574CXY
CSB-EP842574CXY
CSB-BP842574CXY
CSB-MP842574CXY
CSB-EP842574CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized RING finger protein EEED8.16 (EEED8.16), partial CSB-YP842575CXY
CSB-EP842575CXY
CSB-BP842575CXY
CSB-MP842575CXY
CSB-EP842575CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster MOB kinase activator-like 1 (mats) CSB-YP842576DLU
CSB-EP842576DLU
CSB-BP842576DLU
CSB-MP842576DLU
CSB-EP842576DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster CDK5RAP3-like protein (CG30291), partial CSB-YP842577DLU
CSB-EP842577DLU
CSB-BP842577DLU
CSB-MP842577DLU
CSB-EP842577DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster UPF0533 protein CG4953 (CG4953) CSB-YP842578DLU
CSB-EP842578DLU
CSB-BP842578DLU
CSB-MP842578DLU
CSB-EP842578DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Putative rho GDP-dissociation inhibitor 1 (rdiA) CSB-YP842579DKK
CSB-EP842579DKK
CSB-BP842579DKK
CSB-MP842579DKK
CSB-EP842579DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spodoptera frugiperda 60S ribosomal protein L8 (RpL8) CSB-YP842580FKQ
CSB-EP842580FKQ
CSB-BP842580FKQ
CSB-MP842580FKQ
CSB-EP842580FKQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba castellanii Profilin-1B CSB-YP842581AAJ
CSB-EP842581AAJ
CSB-BP842581AAJ
CSB-MP842581AAJ
CSB-EP842581AAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Littorina littorea 60S ribosomal protein L26 (RPL26) CSB-YP842582LEAJ
CSB-EP842582LEAJ
CSB-BP842582LEAJ
CSB-MP842582LEAJ
CSB-EP842582LEAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×